Literature DB >> 16694931

PROTECTIVE ACTIVITY OF NORMAL HUMAN AND ANIMAL SERA FOR SULFAPYRIDINE-TREATED MICE INFECTED WITH PNEUMOCOCCI.

S Spicer1.   

Abstract

Entities:  

Year:  1942        PMID： 16694931      PMCID： PMC435159          DOI： 10.1172/JCI101319

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  THE RELATION OF CIRCULATING ANTIPNEUMOCOCCAL IMMUNE SUBSTANCES TO THE COURSE OF LOBAR PNEUMONIA I. NATURAL IMMUNE SUBSTANCES.

Authors:  O H Robertson; J B Graeser; L T Coggeshall; M A Harrison
Journal:  J Clin Invest       Date:  1934-07       Impact factor: 14.808

2.  EXPERIMENTAL PNEUMOCOCCUS LOBAR PNEUMONIA IN THE DOG : I. Method of Production and Course of the Disease.

Authors:  E E Terrell; O H Robertson; L T Coggeshall
Journal:  J Clin Invest       Date:  1933-03       Impact factor: 14.808

3.  THE PNEUMOCOCCIDAL POWER OF WHOLE BLOOD: II. Estimations in Lobar Pneumonia.

Authors:  W D Sutliff; D R Rhoades
Journal:  J Clin Invest       Date:  1930-08       Impact factor: 14.808

4.  THE PNEUMOCOCCIDAL POWER OF WHOLE BLOOD: I. Description of Method. Results in Individuals with No History of Lobar Pneumonia.

Authors:  W D Sutliff; D R Rhoades
Journal:  J Clin Invest       Date:  1930-08       Impact factor: 14.808
  4 in total
  1 in total

1.  A Study of Sulfapyridine Resistance in Pneumococci.

Authors:  S Spicer
Journal:  J Bacteriol       Date:  1945-07       Impact factor: 3.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.